Koonal Shah
Koonal Shah
National Institute for Health and Care Excellence
Verified email at nice.org.uk
Title
Cited by
Cited by
Year
An EQ-5D-5L value set for England
N Devlin, KK Shah, Y Feng, B Mulhern, B Van Hout
Health Economics 27 (1), 7-22, 2018
8062018
Severity of illness and priority setting in healthcare: a review of the literature
KK Shah
Health policy 93 (2-3), 77-84, 2009
1632009
EuroQol protocols for time trade-off valuation of health outcomes
M Oppe, K Rand-Hendriksen, K Shah, JM Ramos‐Goņi, N Luo
Pharmacoeconomics 34 (10), 993-1004, 2016
1272016
Using QALYs in cancer
M Garau, KK Shah, AR Mason, Q Wang, A Towse, MF Drummond
Pharmacoeconomics 29 (8), 673-685, 2011
1052011
Valuing health at the end of life: a stated preference discrete choice experiment
KK Shah, A Tsuchiya, AJ Wailoo
Social science & medicine 124, 48-56, 2015
822015
Valuing health at the end of life: an empirical study of public preferences
KK Shah, A Tsuchiya, AJ Wailoo
The European Journal of Health Economics 15 (4), 389-399, 2014
602014
New methods for modelling EQ‐5D‐5L value sets: An application to English data
Y Feng, NJ Devlin, KK Shah, B Mulhern, B van Hout
Health Economics 27 (1), 23-38, 2018
592018
Comparing the UK EQ-5D-3L and English EQ-5D-5L value sets
B Mulhern, Y Feng, K Shah, MF Janssen, M Herdman, B van Hout, ...
Pharmacoeconomics 36 (6), 699-713, 2018
582018
A comparison of alternative variants of the lead and lag time TTO
N Devlin, K Buckingham, K Shah, A Tsuchiya, C Tilling, G Wilkinson, ...
Health Economics 22 (5), 517-532, 2013
552013
NICE's social value judgements about equity in health and health care
KK Shah, R Cookson, AJ Culyer, P Littlejohns
Health Economics, Policy and Law 8 (2), 145-165, 2013
542013
Utility values for health states in Ireland: a value set for the EQ-5D-5L
A Hobbins, L Barry, D Kelleher, K Shah, N Devlin, JMR Goni, C O’Neill
PharmacoEconomics 36 (11), 1345-1353, 2018
432018
Multinational evidence of the applicability and robustness of discrete choice modeling for deriving EQ-5D-5L health-state values
PFM Krabbe, NJ Devlin, EA Stolk, KK Shah, M Oppe, B van Hout, EH Quik, ...
Medical care 52 (11), 935, 2014
402014
Is the aim of the English health care system to maximize QALYs?
K Shah, C Praet, N Devlin, J Sussex, J Appleby, D Parkin
Journal of Health Services Research & Policy 17 (3), 157-163, 2012
39*2012
Using patient-reported outcome measures to estimate cost-effectiveness of hip replacements in English hospitals
J Appleby, E Poteliakhoff, K Shah, N Devlin
Journal of the Royal Society of Medicine 106 (8), 323-331, 2013
352013
Valuation of EuroQol five-dimensional questionnaire, youth version (EQ-5D-Y) and EuroQol five-dimensional questionnaire, three-level version (EQ-5D-3L) health states: the …
S Kreimeier, M Oppe, JM Ramos-Goņi, A Cole, N Devlin, M Herdman, ...
Value in Health 21 (11), 1291-1298, 2018
282018
One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands
KK Shah, A Lloyd, M Oppe, NJ Devlin
The European Journal of Health Economics 14 (1), 65-73, 2013
272013
International valuation protocol for the EQ-5D-Y-3L
JM Ramos-Goņi, M Oppe, E Stolk, K Shah, S Kreimeier, O Rivero-Arias, ...
Pharmacoeconomics 38 (7), 653-663, 2020
252020
Views of the UK general public on important aspects of health not captured by EQ-5D
KK Shah, B Mulhern, L Longworth, MF Janssen
The Patient-Patient-Centered Outcomes Research 10 (6), 701-709, 2017
24*2017
Valuing health at the end of life: a review of stated preference studies in the social sciences literature
KK Shah, A Tsuchiya, AJ Wailoo
Social Science & Medicine 204, 39-50, 2018
212018
An empirical study of two alternative comparators for use in time trade-off studies
K Shah, B Mulhern, L Longworth, MFB Janssen
Value in Health 19 (1), 53-59, 2016
202016
The system can't perform the operation now. Try again later.
Articles 1–20